Glaxosmithkline Share News (GSK)
GSK Share
GSK Share
GSK Share
GSK Share
GSK
GSK Share
GSK Level 2
GSK Live
GSK Broker
GSK Directors
GSK Financial
GSK
GSK Short
GSK
Last checked at -
- Turnover falls 4% - Competition from generic brands hurts profit - Full-year 2014 guidance cut GlaxoSmithKline (GSK) on Wednesday slashed its 2014 outlook as it reported a 4% fall in second quarter revenue to £5.6bn. The drugmaker, which is in deep water over a bribery scandal in China, said cor
Read more
LONDON, July 23 (Reuters) - GlaxoSmithKline has seen "very significant" interest from mid-sized pharmaceutical companies and private equity firms in acquiring a range of older drugs that it plans to divest, the drugmaker's chief executive said on Wednesday. Andrew Witty said he hoped to sel
Read moreLONDON, July 23 (Reuters) - GlaxoSmithKline's sales fell by a worse-than-expected 13 percent in the second quarter as its all-important lung drugs struggled in the United States and a strong pound took a bite out of growth. A run of weak quarters highlights the pressure on Chief Executive A
Read more
GlaxoSmithKline (GSK) reports its second quarter interims on Wednesday amid an investigation over a bribery scandal in China. Panmure Gordon said it is "not expecting fireworks" from GSK's results. "In light of our recent downgrade to forecasts due to exchange rate headwinds, we are expecting anoth
Read more
Last checked at